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In order to recognize and combat a diverse array of pathogens the immune system has a
large repertoire of T cells having unique T cell receptors (TCRs) with only a few clones spe-
cific for any given antigen. We discuss how the number of different possibleTCRs encoded
in the genome (the potential repertoire) and the number of different TCRs present in an
individual (the realized repertoire) can be measured. One puzzle is that the potential reper-
toire greatly exceeds the realized diversity of naïve T cells within any individual. We show
that the existing hypotheses fail to explain why the immune system has the potential to
generate far more diversity than is used in an individual, and propose an alternative hypoth-
esis of “evolutionary sloppiness.” Another immunological puzzle is why mice and humans
have similar repertoires even though humans have over 1000-fold more T cells. We dis-
cuss how the idea of the “protecton,” the smallest unit of protection, might explain this
discrepancy and estimate the size of “protecton” based on available precursor frequencies
data. We then consider T cell cross-reactivity – the ability of a T cell clone to respond to
more than one epitope. We extend existing calculations to estimate the extent of expected
cross-reactivity between the responses to different pathogens. Our results are consistent
with two observations: a low probability of observing cross-reactivity between the immune
responses to two randomly chosen pathogens; and the ensemble of memory cells being
sufficiently diverse to generate cross-reactive responses to new pathogens.
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1. INTRODUCTION
The clonal selection theory of adaptive immunity requires that the
immune system is able to produce a large and diverse repertoire
of immune cells (clones), with each cell expressing a receptor with
different antigenic specificity (1, 2). Following infection, the few
clones that are specific for the antigens expressed by the pathogen
proliferate and differentiate into effector cells which control the
infection. Subsequently, the maintenance of an increased number
of these pathogen-specific cells results in long-lasting immuno-
logical memory (3–5). Accurate quantification of changes in the
numbers of antigen-specific cells during infection and vaccina-
tion, together with advances in molecular and cellular biology, has
allowed us to make considerable progress toward understanding
the dynamics of the generation of immune responses (3, 6, 7)
and the requirements for pathogen control (8, 9). Furthermore,
deep sequencing technology has provided a first quantitative snap-
shot of the diversity of immune cells (10, 11). These technological
advances set the stage for understanding the relationship between
the diversity of immune cells (the repertoire) and immune pro-
tection from an extensive array of pathogens to which we are
exposed.
We begin by outlining our current understanding of T cell
receptor diversity and discussing problems associated with the
quantification of the T cell repertoire. Next, we explore how diverse
the immune system needs to be by exploring the relationship
between the diversity of the T cell repertoire and its ability to
provide protection from pathogens. Finally we consider how the
degree of specificity of T cells (often defined by measuring how
cross-reactive they are) affects the relationship between the reper-
toire and host response to a given pathogen. We focus on αβ T
cells and the term “T cell” refers to the CD8 subpopulation of T
cells unless we explicitly specify a different subpopulation.
We have intentionally used simple models and calculations
because, in the absence of detailed information on the terms and
parameters, simpler models frequently generate more robust qual-
itative results than complex models (12, 13). The focus of the paper
is to highlight the limitations arising from uncertainties in cur-
rent estimates of parameters, and in particular to gain maximum
insight from the one key parameter – the precursor frequency of
T cells specific for different epitopes – that can be accurately mea-
sured. Throughout this paper we emphasize current puzzles and
problems and, where possible, suggest new approaches to solving
them.
2. MEASURING THE DIVERSITY OF THE T CELL REPERTOIRE
2.1. WHAT IS THE POTENTIAL REPERTOIRE?
T cells develop from progenitor cells in the thymus where the
germline T cell receptor (TCR) α and β genes undergo somatic
recombination of the V-J and V-D-J gene segments, respectively
(14, 15). The antigenic specificity of each T cell is determined
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by the amino acid sequence of these rearranged TCR genes, and
in particular by the hypervariable complementarity determining
region 3 (CDR3) that mostly account for direct contacts with
peptides presented on major histocompatibility complex (MHC)
proteins, and is encoded by the junction of the V, (D), and J gene
segments (16). The diversity of generated TCR genes is therefore
due to: (1) selection of one from a number of possible V, D, and J
gene segments, (2) semi-random cleavage of recombination hair-
pin intermediates, and (3) N-nucleotide addition and subtraction
at the junction of V, D, and J genes (17, 18). Finally, the pairing of
different α and β chains to generate a functional receptor results
in additional diversity (19).
How many different T cell receptors can be generated? The first
steps toward understanding the magnitude of the diversity of the
T cell repertoire came from the pioneering studies that identified
the molecular mechanisms involved in the recombination of V,
(D), and J gene segments and N-region diversification described
above for the generation of the α and β TCR chains (14, 15, 19). It
was estimated that these processes together with pairing between
different α and β chains could give rise to around 1015 possible αβ
TCR (19). The question of the potential number of TCR sequences
has recently been revisited and significantly larger estimates for
the diversity of the TCR β chain were obtained (20, 21). Muru-
gan et al. (21) used statistical analysis of non-productive TCR β
chain to conclude that the CDR3 (variable) region of the TCR β
chain alone has a potential diversity of ~1014 different sequences.
They used empirical β chain data to show that N-nucleotide inser-
tions at the V-D and D-J junctions are uncorrelated, their length
distributions are nearly identical and their lengths could exceed
six nucleotides which was assumed in previous estimates (19).
We might expect that a similar analysis would result in upward
revision for the potential diversity of the α chain (though the esti-
mates of diversity would increase less than for the β chain because
the α chain has only one V-J junction). This will result in a truly
enormous potential repertoire of over 1020 for the αβ TCR.
2.2. WHAT IS THE REALIZED REPERTOIRE IN AN INDIVIDUAL?
Only mature T cells that have passed thymic selection (naïve T
cells) can be employed in immune responses for protection against
pathogens. Thus, in order to understand the balance between
diversity and protection, the most important measurement is the
“realized” T cell diversity in an individual (i.e., the actual number
of different TCR in the mature T cell compartment).
The diversity of the naïve T cell repertoire was initially esti-
mated prior to the advent of deep sequencing technologies by
the use of spectrotyping, which involved amplifying mRNA from
particular V-J sequence combinations, separating the amplified
products on the basis of size, and exhaustive conventional sequenc-
ing of a particular length CDR3 product. The diversity of TCR
sequences in this sample was then extrapolated to the total T cell
population.
2.2.1. TCR diversity and clone size in humans
Arstila et al. (22) used spectrotyping to estimate that there are 106
β chains in the blood each pairing on average with at least 25 dif-
ferent α chains, and consequently proposed a lower bound to the
estimate of the T cell repertoire in humans of around 2.5× 107
specificities. Advances in deep sequencing have confirmed that
estimation of β chains is in the range of 1− 4× 106 (20, 23, 24).
There is however considerable uncertainty about the extent to
which 2.5× 107 specificities underestimates the diversity of T cells
in humans (25, 26). A repertoire of 2.5× 107 suggests a naïve
clone size on average of over 4× 103 cells (>1011/(2.5× 107)).
This could happen if each clone gets produced multiple times or
if once produced a given clone would undergo about 12 rounds of
division. The first scenario is unlikely, given the very large estimates
of potential diversity (19–21). If the second scenario happens, it
must occur in the periphery. Expansion of clones in the thymus
would result in a much lower frequency of detectable T cell recep-
tor excision circles (TRECs) in the naïve pool of recent thymic
emigrants than is currently observed (27–29). Arstila et al. points
out that naïve T cells in the periphery could divide more than 12
times during a human lifespan (26). However, as the total num-
ber of naïve T cells remains relatively stable (because division is
balanced by death) changes in clone size would have to arise from
stochastic drift and this seems unlikely.
2.2.2. TCR diversity and clone size in mice
Interestingly, it was estimated that TCR β chain diversity in mouse
spleen is quite similar to the one measured in human blood. The
β chain repertoire of 5− 8× 105 specificities with each variable
domain of β chain sequence being shared by 30–40 T splenocytes
have been reported using spectrotyping technology (30). Pairing
with α chain was estimated to add a factor of 2.4 and resulted in
total αβ TCR diversity of 2× 106. Taking into account that there
are 2× 107 splenocytes it was estimated that the clone size of αβ
TCR is equal to 10 cells (30). The bias in recombination and α-β
TCR pairing will likely affect the T cell clone size. A recent study
that enumerated the number of naïve T cells specific for differ-
ent epitopes suggests that there are between 15 and 1500 unique
cells in the mouse spleen specific for any given epitope, implying
that the number of naïve cells with a given TCR α-β combina-
tion is very small, and indeed that most clonotypes have clone
size of one (31, 32). This is in contrast with the earlier estimates
that suggest an average clone size of 10 cells/clone in the spleen
(30). Consequently, it brings the repertoire in the spleen toward
the total number of naïve T cells in the spleen, and increases the
lower bound of the total αβ T cell repertoire in the mouse by an
order of magnitude. In this case the estimate of 2× 107 specifici-
ties becomes very close to a lower bound estimation for human T
cell repertoire.
2.2.3. Limitations in estimates of realized diversity
Current estimates of the realized diversity are lower bounds. The
limitations of these studies is the lack of information on the pairing
of different TCR α and β chains. Bulk sequencing of a single chain,
or even of both TCR α and β chains, is not sufficient to inform us
of the potential diversity (33). In principle this problem could be
comprehensively addressed by single cell sequencing that would
obtain linked α and β chain sequences, but this remains techni-
cally and financially infeasible for the large sample sizes required to
evaluate naïve repertoires with high diversity (34); the cost of sin-
gle cell sequencing remains at $1 per cell, making the analysis of T
cells from a single mouse more than a $10 million experiment! Oil
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emulsion lysis strategies (35) combined with micro-sequencing
have increased the capacity of such single-cell studies, but these
still are only able to capture <1% of the total naïve T cell reper-
toire in a single mouse. New techniques or methods need to be
developed.
In order to have an accurate and comprehensive quantitative
description of diversity, it is important to define what we mean
by diversity. We can describe T cell repertoire diversity in terms
of summary measures of diversity borrowed from the ecologi-
cal literature. This includes enumerating the number of distinct
clones or computing the Simpson diversity index (36) that takes
into account the number of clones and their frequencies. However
these summary approaches compress all of the diversity infor-
mation into a single number. A more comprehensive statistical
approach retains the frequency distribution of different clone sizes.
In Figure 1 we show a plot of the frequency distribution of β chain
sequences in the mouse naïve T cells using preliminary data. We
find a majority of β chain sequences are present at low frequencies
and fewer sequences occurring at much higher frequencies. A key
problem is that we do not know the α chain sequences pairing
with each of these β chains, and this restricts our ability to infer
diversity of T cells from these observations.
Several clones in Figure 1 have very high frequencies and the
exact underling mechanisms are not known. The sequences which
are more common (generated more frequently) are more likely to
be shared between different individuals. It was reported that inbred
mice and individuals with the same MHC share some T cells with
identical receptors (11, 20, 37, 38). These constitute “public” T cell
clones, in contrast with the majority of the T cell clones that are
unique to an individual and comprise the “private” part of a reper-
toire response. In general, the frequency of public TCR clonotypes
exceeds what is expected if T cells were chosen at random with
equal probability from the total potential repertoire, and perhaps
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FIGURE 1 | Plot of the frequency distribution in the β chain sequences
of naïve CD8 T cells. Naïve (CD44lo) CD8 T cells from C57Bl/6 mice were
isolated by magnetic beads and >98% purity confirmed by flow cytometry.
Genomic DNA was subjected to TCRβ V-J multiplex DNA sequencing and
the distribution of unique in-frame CDR3 sequences is plotted. We note
that the term “clone” on the x and y axis labels refers to clones based on β
chain sequences alone.
not surprisingly, the clone size of public T cells is higher than that
of private T cells in the naïve T cell repertoire [(33); Blattman
et al. unpublished results]. This has been suggested to arise due
to MHC restriction during thymic selection, biased frequencies of
recombination, as well as degeneracy in the genetic code which
allows more than one nucleotide sequence to give rise to the same
amino acid sequence (33, 39). The factors involved in the evolu-
tion and/or selection of public T cell clonotypes and their possible
role in the control of infections remain puzzling questions.
In summary we have estimates of the potential repertoire of
upward of 1020 TCR. The estimates of the realized repertoire
suggest lower bounds of 2.5× 107 and 2× 106 in humans and
mice. Two puzzles which we will address are: why humans and
mice might have similar repertoire sizes (Section 3.2); and why
the potential repertoire so greatly exceed the realized repertoire
(Section 3.3).
3. UNDERSTANDING DIVERSITY, THE REPERTOIRE AND
CROSS-REACTIVITY
In this section we use quantitative calculations to explore the con-
sequences of the observations on the repertoire described in the
previous section. We begin by looking at whether the diversity of
the repertoire may be explained by the relationship between diver-
sity and protection. We then address questions associated with our
current understanding of repertoire diversity and cross-reactivity.
3.1. RELATIONSHIP BETWEEN DIVERSITY AND PROTECTION
Clearly a large repertoire is required to generate a T cell response
to a diverse array of pathogens. However, to our knowledge, few
empirical studies consider the relationship between the repertoire
and protection. To some extent the paucity of experiments on
this topic is because of difficulties in quantifying the repertoire
(see earlier discussion). Studies on mice, expressing a single fixed
transgenic TCR chain (either α or β) that measure the number
of different paired endogenously recombined TCR chains, have
shown that pairing is not completely random, as these mice express
repertoires of reduced diversity and altered V gene usage (40–43).
However, even in these mice there is still sufficient diversity to
generate effective, albeit reduced, responses to control pathogen
infections.
A relatively simple calculation can be made to estimate how
diverse the TCR repertoire needs to be in order to provide reli-
able protection following infection with a pathogen. To provide
protection against a pathogen there must be some number of
clones present in the repertoire that are specific for that pathogen.
Here, we extend the logic outlined in (44, 45). Let R be the T cell
repertoire and let pi be the probability that a randomly chosen
TCR binds to ith of the k epitopes derived from a given pathogen
(i= 1:k). Note that pi is also equal to the precursor frequency of T
cells for ith epitope. A pathogen is not detected if all R naïve T cell
clones fail to recognize it, and this will happen with probability.
PE = (1− p1)R(1− p2)R ... (1− pk)R
≈ exp(−p1R) exp(−p2R)... exp(−pk R) = exp
−R k∑
i=1
pi

(1)
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FIGURE 2 |The probability a pathogen is not detected, PE, as a function
of the log of the precursor frequency p and the log of the naïve T cell
repertoire R . The numbers on the contour lines in the plot indicate log PE
values. Black color corresponds to the values of PE below the threshold of
10−10.
which gives
R = − ln(PE )∑k
i=1 pi
(2)
Equation (2) tells us how big the repertoire must be to detect at
level PE. Figure 2 shows how the probability that a pathogen is
not detected by the immune system depends on the repertoire size
and the total precursor frequency p=∑ pi . There is a very rapid
decline in the probability of not being detected once the product
of p and R becomes sufficiently large. We should note that PE is
often termed as the “probability of escape” but it should not be
confused with the usage of the term “escape” that refers to the
generation of escape mutants in T cell epitopes after recognition
has already occurred following infections such as HIV.
If we know the precursor frequencies for pathogen epitopes and
total number of epitopes we can relate the probability of being not
detected to the repertoire R. We have much more accurate esti-
mates for precursor frequencies against specific epitopes than for
repertoire sizes (31, 46, 47). A recently developed method that
combines pMHC tetramer staining with magnetic particle-based
cell enrichment allows for the direct measurement of the frequency
of naïve cells to different epitopes for both mice and humans
(31, 48). Figure 3 shows the density distribution of naïve T cell
precursor frequencies for different CD8 T cell epitopes in mice
determined by this cell enrichment method using MHC tetramers
complexed with different class I-restricted peptides (31). The total
number of responded cells per mouse (naïve precursor frequency
multiplied by total CD8 T cell number) varied from 15 in response
to the L-338:Db epitope of LCMV to 1500 in response to an epitope
from the murine cytomegalovirus (31). These estimates concur
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FIGURE 3 | Density distribution plotted from the precursor frequencies
of naïve CD8 T cells for different epitopes reported in (31). The tick
marks on the top of the x-axis indicate individual epitopes. Note the log
scale on the x-axis.
with previous in vivo estimates of precursor frequencies. These
studies transferred different numbers of naive epitope-specific T
cells and measured the proportion of the response arising from
expansion of host versus donor cells following virus infection (46,
47). The effect of changing precursor frequencies on the proba-
bility of been undetected, PE, is given by equation (2) and plotted
in Figures 2 and 4. Note, that precursor frequencies plotted in
Figure 3 are likely biased toward immunodominant epitopes.
Immunodominance is a complex issue, and the major factors that
affect the magnitude of the T cell response to a particular epitope
include: the processing and presentation of peptide on MHC (i.e.,
the amount of epitope); the number of precursor cells for this epi-
tope; their affinities for the epitope; the extent of their recruitment
and competition between the T cells for this and other pathogen
epitopes (31, 49–51).
3.2. SCALING AND THE CONCEPT OF A “PROTECTON”
We now consider the scaling of the repertoire with the size of
the organism. A few pathogen-specific precursors in a tadpole are
likely to be able to mount a faster and more effective response
than the same number of cells in an elephant (52). Langman
and Cohen proposed the basic functional unit, the “protecton,”
capable of providing robust protection. They suggested a tadpole
(smallest vertebrate) has a single “protecton,” and the number of
“protectons” scales with the size of an organism. Localized infec-
tions are surveyed by a draining lymph node rather than the entire
immune system and thus we expect this unit should contain at
least one “protecton.” Clearly the calculations for PE (how diverse
the immune system needs to be to recognize pathogens) pertains
to the “protecton” [see equations (1) and (2)].
Lets estimate the diversity in a “protecton.” Figure 4 shows
how the probability of being undetected depends on the size of
the repertoire R for different total precursor frequencies. The pre-
cursor frequency of T cells specific for a pathogen is, to a first
approximation, the sum of the precursor frequencies for that
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FIGURE 4 | Probability that a pathogen is not recognized PE (y-axis) is
plotted as a function of the repertoire (x-axis) for indicated
pathogen-specific precursor frequencies (gray lines). LCMV case
(p=4× 10−5) is shown in red color.
pathogen’s different epitopes presented by MHC proteins. This
can be estimated for LCMV by combining reported naïve precur-
sor frequencies for few measured epitopes (31) and measurements
of the fraction of the total LCMV specific responses which is
directed against these epitopes (53). This gives us a total pre-
cursor frequency for LCMV specific T cells equal to ~4× 10−5,
and from Figure 4, a level of protection PE= 10−3 (i.e., 1 in 1000
“protectons” will fail to recognize LCMV) requires the repertoire
in the “protecton” to be about 1.7× 105. In order to know the
level of protection against diverse pathogens we need to know the
distribution of precursor frequencies to pathogens. The existing
data gives us lower bounds (because only cells specific for a few
epitopes are measured) to the precursor frequencies of viruses
such as MCMV (~1.3× 10−4), Influenza (~4× 10−5), Vaccinia
(~1.1× 10−4), RSV (~4.5× 10−5), HSV (~2.9× 10−5), and VSV
(~10−5) (31). The precursor frequencies for those viruses are com-
parable or greater than that for LCMV with the exception of VSV
and HSV for which only single epitope data were reported in (31).
If this trend holds (i.e., the precursor frequency per pathogen is
>10−5) it might suggest that having a repertoire of 7× 10−5 is suf-
ficient to give robust protection at the level PE= 10−3, and thus
define the size of the “protecton.” For PE one order of magnitude
lower and higher, i.e., PE= 10−4− 10−2 will require a repertoire
of ~9× 105− 5× 105, suggesting that our estimate is quite robust
to changes in PE (see Figure 4). We can expect the area of local
surveillance (a small lymph node) in mice to have at least this
number of different T cells.
How much bigger should the total repertoire size be so that the
area corresponding to one“protecton,”randomly filled with T cells
from the total circulating cells, has a relatively low number of clone
repeats? We estimated that if f is a fraction of clone repeats in the
“protecton” area with m cells, the total repertoire size R is bounded
as (1− f)(m− 1)/(2f)<R< (m− 1)/(2f). For example, for 5 or
10% of clone repeats in m we will have a multiplication factor
for m for the total diversity in the ranges ~9.5− 10 or ~4.5− 5,
respectively. To derive this formula we used two assumptions: first,
the clones are equal in size and second, the size of total repertoire
multiplied by clone size is much bigger than the size m. These
calculations show that the total diversity doesn’t need to be much
higher than the diversity in a “protecton.”
Several theoretical papers previously estimated that the reper-
toire of B and T cells scales as ln(cM ), where c is a constant and
M is the mass of an organism (45, 54). It was also estimated that
humans should have B cell repertoire 2–5 times larger than mice
(45) and similar reasoning could be apply to T cell repertoire.
The diversity of the repertoire is linked to clone size and it was
estimated that the size of T cell clones should scale as M and, cor-
respondingly, the total number of T cells should scale as Mln(cM )
(45). Wiegel and Perelson’s estimate shows that the repertoire in a
human need not be much higher than that in a mouse even though
the number of naïve cells in these organisms differs by over 103
fold [mice have ~108 T cells (30, 46) and humans between 1011
and 1012 T cells (22, 55, 56)].
Another reason for why humans need a more diverse reper-
toire than mice pertains to the number of pathogens to which
they are exposed. As humans live longer than mice, other factors
being equal, they will be exposed to more pathogens and require
a lower PE.
3.3. EVOLUTIONARY CONSIDERATIONS: WHY ENCODE SUCH A
DIVERSE POTENTIAL REPERTOIRE?
The calculations described in the previous section are consistent
with the diversity of the repertoire that is observed in mice and
humans (22, 30) (lower bound diversity in the range of 2× 106
to 2.5× 107 unique αβ T cells), and the diversity is sufficient to
generate a low probability that a given pathogen is not detected
(PE< 10−4). What those estimations don’t explain is why the
immune system is able to generate a potential diversity of more
than 1015 T cell specificities (19–21) that is vastly in excess of the
realized repertoire?
Let’s consider a number of potential explanations for why
the potential repertoire needs to be much larger than the real-
ized repertoire. One simplistic explanation takes into account the
observation that most of the generated progenitor T cells are
deleted during positive and negative selection in the thymus. If a
fraction f of the T cells generated in the thymus gets selected (i.e.,
pass positive or negative selection) then the potential repertoire
should be (1/f) times the peripheral repertoire. Since only 3–5%
of T cells pass thymic selection (57, 58), the potential repertoire
need only be at most 33-fold higher than the realized repertoire,
thus ruling out this explanation.
A second potential reason is the need to successfully recognize
peptides in the context of the hundreds of MHC alleles in the
population. The reported extent of thymic selection (see previous
paragraph) allows us to reject this hypothesis – different cells may
be selected in different MHC backgrounds but in all cases 3–5%
of T cells pass thymic selection.
A third potential reason is the need to prevent pathogen escape
mutations – mutations in an epitope that prevent it from being
recognized by the immune system. To a first approximation hav-
ing more than one epitope is the key factor that prevents escape – if
the pathogen has k epitopes the probability of escaping all epitopes
declines asµk, whereµ is the probability of mutation leading to the
loss of one epitope. The number of epitopes to which a response
is generated involves many factors such as immunodominance,
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MHC diversity, and T cell diversity. The relationship between these
quantities is not understood and we do not know the contribution
of T cell diversity to immunodominance due to problems in esti-
mating TCR diversity described above. However from Figure 4 we
note that the repertoire is sufficiently large to enable robust detec-
tion of subdominant epitopes in a biologically reasonable range of
precursor frequencies [Figure 2; (31)].
A fourth potential reason considers the temporal aspect and
changes in the repertoire over the lifespan of an individual. Thymic
emigration results in a constantly changing repertoire over time.
The total number of different T cells present in the individual over
its lifespan could be much greater than its repertoire at any given
time. In humans, for example, if we assume that thymic emigration
is of the order of 107− 108 cells per day (59, 60) then the realized
repertoire over a lifespan might be as much as 1012 specificities
which is much closer to the potential repertoire. There are two
problems with this approach. First, it does not explain why mice
have about the same potential repertoire as humans since a similar
calculation for mice would result in a realized repertoire over the
lifespan several orders of magnitude lower than humans. This is
because both mice thymic output of the order of 106 cells per day
(61–63) and lifespan are smaller than for humans. Second, protec-
tion is related to the repertoire at a given time point. Changing the
particular clones in the repertoire over time does not help unless
the relevant clones are present at the time of infection or generated
during the infection and consequently able to help with clearance
of the pathogen. The continual influx of cells of new specificities
is thus unlikely to be of significance for acute infections which are
relatively brief, but has been suggested to contribute to the mainte-
nance of the response during persistent infections (64–66). In the
case of persistent infections, however, an occasional new pathogen-
specific clone is unlikely to clear the infection if the much larger
number of clones at the onset were not able to do so – and the new
clone is likely to be exhausted rapidly. Finally, temporal aspects
could change the total repertoire if we consider the sum of both
naïve and memory compartments. As naïve cells convert to mem-
ory cells each time we confront an infection, the replenishment
of naïve compartment with the cells of new specificities would
increase the total repertoire (naïve plus memory compartments).
However, even if the memory compartment is as diverse as the
naïve, the total diversity would increase at most by a factor of 2 in
comparison to the naïve compartment alone. Taken together we
don’t expect temporal aspects to account for the differences in the
sizes of the potential and realized repertoires.
We now describe a new evolutionary explanation that we call
“evolutionary sloppiness.” The process of generation of diversity
by recombination and N nucleotide addition and deletion are
sloppy processes. To reduce the amount of diversity that can be
generated might require putting additional costly constraints on
these processes. This would explain why organisms are able to
generate far more TCR diversity (in excess of 1015 TCR) then is
needed. Finally we note that not all aspects of biology result in
perfectly optimized solutions (67).
Additionally, it has been suggested that the thymus is an energy-
and resource-expensive organ (68) but these energetic costs have
yet to be quantified. Energetic costs to cell production and thymic
selection would favor expansion of clones after thymic selection
(i.e., to have an amplifier). This amplification could take place
in the thymus or periphery and would scale with the size of the
organism. This would result in clone sizes in men being ~1000-fold
higher than in mice, which is unlikely (see discussion on TRECs
in Section 2.2.1). Accurate estimates for clone sizes in humans and
mice should allow us to resolve this question.
3.4. T CELL CROSS-REACTIVITY
Cross-reactivity is related to the observation that a given T cell can
respond to more than one epitope, including epitopes that show
strong sequence homology or completely unrelated (69–76). As
might be expected the frequency of the former is higher than that
of the latter. Flexible TCR-pMHC binding sites were suggested as a
possible structural explanation for known high degree of αβ TCRs
cross-reactivity to different pMHCs (77–80). Cross-reactivity can
also arise in T cell clones with incomplete allelic exclusion at the
α chain loci resulting in one β chain pairing with two different
α chains. An upper bound on the frequency of such clones was
estimated to be 30% (81–83).
The pioneering experiments of Selin and Welsh (69) found that
the CD8 T cell responses of mice to pathogens such as the Pichinde
virus (PV), Vaccinia virus (VV), and Lymphocytic choriomenin-
gitis virus (LCMV) showed high levels of cross-reactivity. They
found that prior vaccination with one of these viruses expanded
a specific CD8 T cell subset that could be boosted during stimu-
lation by the other viruses and showed an unexpectedly complex
relationship between the responses to different viruses with asym-
metry depending on the order of viral exposure (infection A
followed by B stimulated different cross-reactivity than B followed
by A) (69, 71, 84). In a very recent paper (80) the cross-reactivity
studies were extended to analysis of the CD4 T cell repertoire
against pathogens to which individuals had never been exposed.
Surprisingly, they found that a large fraction of the CD4 T cells
specific for these pathogens exhibited a memory phenotype and
suggested that they had been generated by cross-reactive responses
to other previously encountered pathogens including heterologous
infections or environmental antigens.
The extent of cross-reactivity between the immune responses
to different pathogens is of practical importance. Murine stud-
ies have not only demonstrated the presence of T cells that could
cross-react between different pathogens such as PV,VV,and LCMV,
but also showed that this cross-reactivity affected pathogenesis
during subsequent infection (84–86). If these occurrences of cross-
reactive responses are rare, then the examples above are simply
interesting curiosities. If, on the other hand, cross-reactivity is
common then we would need to move from our current paradigm,
which looks at each infection independent of other infections, to a
more complex view that incorporates the terms for the interactions
between the immune responses to different pathogens. Thus a key
step is to quantify the extent of cross-reactivity in the immune
responses to different pathogens.
How can we predict the level of cross-reactivity between two
pathogens? The current approach is based on the observation that
number of possible peptide-MHC complexes is much larger than
the total number of T cells, suggesting that a given T cell must be
able to recognize many different peptide-MHC (i.e. have a high
level of cross-reactivity) (87, 88). However it is not clear how these
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parameters can be measured. We propose an alternative calcula-
tion that allows estimation of the extent of cross-reactivity from
the precursor frequency of T cells for pathogens – a parameter that
can be reliably determined. Using slightly modified notation from
(87) we first define four parameters:
R Repertoire (the number of clonotypically different naïve T cells
in the repertoire)
r The number of different T cell clonotypes that will respond to
the same peptide
N The total number of potentially immunogenic foreign peptides
in the environment
n The number of different peptides to which a single T cell
clonotype will respond
These four parameters are linked by the conservation equa-
tion (87):
rN = nR (3)
Lets suggest that a given pathogen has k epitopes to which T
cells can mount a response. For a given T cell, the probability
to recognize at least one epitope from a given pathogen could be
written as:
1−
[
1− n
N
]k
(4)
The probability that the same T cell will recognize at least one
epitope on each of two pathogens with k epitopes (i.e., will be
cross-reactive) will be a square of expression equation (4) and the
probability to find at least one cross-reactive clone is equal to:[
1−
[
1− n
N
]k]2 × R (5)
Note, that in derived equation (5) we don’t know the parame-
ters k, n, and N which makes it very difficult to apply directly.
Interestingly, for one epitope (k = 1) and with application of
cross-reactivity equation (3) the equation (5) simplifies to:[
1−
[
1− n
N
]]2×R = [1− [1− r
R
]]2×R = [ r
R
]2×R (6)
Under the assumption that all naïve T cells able to respond to a
given epitope are clonotypically different, which is supported by
recent data (31, 80), we can think of r/R as a precursor frequency
for a given epitope. The problem of estimating cross-reactivity in
this case will be similar to the problem of estimating the proba-
bility of randomly choosing a two-colored ball from an urn when
the frequencies of each of two colors are known. Interestingly, the
measured naïve precursor frequencies for different immunogenic
epitopes are similar for mice and humans and range from 1 to
100 cells per million cells (31). According to equation (3), this
similarity immediately implies that cross-reactivity of each T cell
receptor, n, is in the same range for mice and humans.
For the case when k> 1, we could not directly use the formula
(5), due to unknown parameters, but can use a simple probabilis-
tic calculation based on sampling multiple colored balls. We can
write the frequency of cross-reactive cells between two randomly
chosen pathogens (A and B) in terms of the precursor frequencies
of T cells to these two pathogens, pA and pB, and the total number
of cells T:
Expected number of cross-reactive cells = pApB × T (7)
and if we have clones of same size equal to T /R,
Expected number of cross-reactive clones = pApB × R (8)
where R equals the repertoire (the number of different T cell clones
in each individual). When the average number of cross-reactive
clones is less than one, equation (8) gives us the probability of
observing a cross-reactive response between two pathogens in a
single individual. We can use this framework together with the
data on precursor frequencies (31) described in Figure 2 to get
an estimate of the extent of cross-reactivity between the responses
to unrelated pathogens. As described earlier we have an approxi-
mate precursor frequency per epitope of 10−5, and a precursor
frequency per pathogen, with LCMV as an example, of about
4× 10−5. If we assume there are about 2× 107 naïve CD8 T cells
per mouse (89) then the number of cross-reactive cells between
two unrelated pathogens will be ~0.032, which suggests cross-
reactivity is very rare (a single cross-reactive clone will be found
<4% of the time). In order to observe cross-reactivity between two
random pathogens in a mouse we would need to have a precursor
frequency per pathogen of at least 2.2× 10−4, assuming that pre-
cursor frequencies are similar for both pathogens. There are quite
a few reported examples of cross-reactive T cell responses to differ-
ent pathogens. In addition to the experiments of Selin and Welsh
(69), cross-reactivity has been reported between influenza virus
and hepatitis C virus (72), EBV (73) or HIV (74), LCMV and vac-
cinia virus (75), and coronavirus and human papillomavirus (76).
It remains to be seen if the observed cases of cross-reactivity arise
from a reporting bias (failure to observe cross-reactivity between
two pathogens is unlikely to be reported) or because some of the
assumptions of our model are incorrect and need to be modified.
For example, we assume all T cell clones have the same level of
cross-reactivity – and introducing heterogeneity may dramatically
increase the chances to observe cross-reactivity.
Even if cross-reactive T cell responses to two specific pathogens
are rare, the accumulation of many successive infections could
result in fairly frequent cross-reactivity between a new pathogen
and sum of all the pathogens the individual has previously encoun-
tered. This is what was observed when T cell precursor frequencies
were measured for novel pathogens in blood from adults (80).
The precursor frequency for cells recognizing a self-antigen or an
unexposed viral epitope was the same as earlier estimated in mice
and humans (31) and ranged from one to ten cells per million of
CD4 T cells. The surprise was that over half of the precursor cells
specific for novel pathogens such as HIV (to which an individual
had never been exposed) were of the memory phenotype (80),
suggesting that they may have arisen as a consequence of exposure
to a different previously encountered pathogen(s). Alternatively,
these memory cells could be pseudo-memory cells acquired via
the process known as “homeostatic proliferation” and driven by
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interaction with low-affinity self pMHCs that previously induced
positive selection (90–94).
The Su et al. paper (80) raised an interesting question: why
do memory cells invariably contribute about 50–80% of the pre-
cursors to pathogen the individual has never encountered? One
possibility is that the memory repertoire is sufficiently large to be
“complete.” In this case if we draw the same amount of cells from
either naïve or memory compartments (or mixture from both) we
will have the same precursor frequency for a pathogen. Then the
relative contribution of naïve and memory cells to precursors is
equal to their relative frequencies, and is scaled by the stimulation
threshold which is known to be lower for memory cells.
We note that our equation (7) allows an estimation of cross-
reactivity for unrelated pathogens or peptides and, based on
reported precursor frequencies for different epitopes, we expect
cross-reactivity to be rare. Several studies allowed to estimate the
rate of cross-reactivity for closely related peptides. Su et al. (80)
identified potential pathogens responsible for generating T cells
cross-reactive to HIV in HIV-negative individuals as follows: they
generated clones from the HIV precursors and identified two epi-
topes to which these clones were specific. Then using a BLAST
search of pathogen sequences they identified 24 sequences similar
to the two HIV epitopes. About 21% of the HIV clones responded
to two of the BLAST sequences corresponding to environmen-
tal pathogens. This number is comparable to result obtained in
the earlier study, which showed that although the majority of 171
generated variant peptides of strongly immunodominant HLA-
A2-restricted HIV gag epitope were able to bind HLA-A2, only
one third were recognized by specific T cells (95). These two
studies may give the rate of cross-reactivity for closely related pep-
tides (21–33%) and could be particularly important in the context
of a variable virus with an increased rate of mutations within
epitopes (96).
Cross-reactive responses may be of clinical importance in
the generation of pathology and autoimmunity. Several stud-
ies pointed that cross-reactivity may be the cause of increased
immunopathology during successive unrelated viral infections
(84–86) or as a result of application of T cell based therapy (97,
98). Expansion of cross-reactive T cell clones due to previous infec-
tions may underlie autoimmune diseases (99–101). Sometimes a
pathogen epitope stimulates T cells in the context of a different
MHC from the self-epitopes that react with these T cells, for exam-
ple, Epstein-Barr virus EBN13-HLA-B8-specific cytotoxic T cells
were shown to cross-react with a variety of self peptides presented
by HLA-B35 (102). Together these observations point out that
cross-reactive T cell responses might operate on different levels
and much remains to be done to understand the extent of cross-
reactivity and how it may differ in CD8, CD4, and regulatory
populations of T cells.
4. SUMMARY
We have reviewed current estimates of the T cell repertoire and
identified their key limitations. Further progress will require the
development of methods to determine the pairing of TCR α and β
chains and thus more accurate quantification of the T cell diversity.
Current estimates raise the puzzling question of why the potential
repertoire is many orders of magnitude greater than the realized
repertoire. We suggest that existing hypotheses are not able to
explain this puzzle and have proposed an alternative hypothesis of
“evolutionary sloppiness.”
One of the interesting observation that became obvious from
our estimations is that precursor frequency per pathogen inher-
ently links the TCR diversity and cross-reactivity which allows to
predict the level of cross-reactivity between two random pathogens
or unrelated peptides. Our estimates suggest that although cross-
reactivity is a rare event for immunologically naïve individuals,
probability to see the cross-reactive memory T cells becomes very
high with an increase in successive infections.
Finally we note that we need to move from our current
paradigm, which looks at each infection independent of other
infections, to a more complex view that incorporates the terms
for the interactions between the immune responses to different
pathogens.
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